Biosortia
1 known investors
Biosortia is a drug discovery company whose Industrial-Scale Microbiome Mining (ISMM) platform extracts community-derived small molecules from the microbiome at kilogram-to-ton scale, using an AI tool (BiosortAI) to prioritize evolutionarily shaped compounds. Its lead program targets obesity and metabolic disease, with expansion into IBD, gut-brain neuromodulation, oncology, pain, and anti-infectives.